All stories tagged :

Pr Newswire

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy...

admin
Pr Newswire

TCTM Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price

admin
Pr Newswire

XbotPark Showcases Over 30 Incubated Hardware Startups at CES 2025

admin
Pr Newswire

Seongnam Pavilion and Delegation Send Record-Breaking 41 Companies to CES 2025:...

admin
Pr Newswire

Jasper Therapeutics Reports Positive Data from BEACON Study of Briquilimab in...

admin
Pr Newswire

MoonLake initiates three new clinical trials and further expands the portfolio...

admin
Pr Newswire

EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU Technology

admin
Pr Newswire

Bracco and Aenitis Join Forces to Develop “Acoustic Beads” for Advanced...

admin
Pr Newswire

BioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of...

admin
Pr Newswire

Published in Annals of Oncology: Disitamab Vedotin Combined with PD-1 Inhibitor...

admin
Pr Newswire

Route Mobile Partners with PT MRT Jakarta to launch first-of-its-kind WhatsApp...

admin

Featured

Pr Newswire

Virbac : Declaration of the number of shares and voting rights...

admin
Pr Newswire

Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessa’s...

admin
Pr Newswire

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase...

admin
Pr Newswire

Strüngmann Award Honors Araris Biotech Founding Team as 2025 Winner

admin
admin

Virbac : Declaration of the number of shares and voting rights...

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal...